MindWalk Holdings (HYFT) Operating Expenses (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Operating Expenses of $4978.1 for Q2 2026, down 67.83% year-over-year from $15474.8 in Q2 2025, and down 99.89% quarter-over-quarter from $4.4 million in Q1 2026.
MindWalk Holdings (HYFT) Operating Expenses (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Operating Expenses for 7 consecutive years, with $4978.1 the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Expenses fell 67.83% year-over-year to $4978.1; the TTM figure through Apr 2026 stood at $4.1 billion (down 4.01% YoY), while the FY2026 annual figure was $17.6 million, down 42.6% from the prior year.
- Operating Expenses retreated to $4978.1 in Q2 2026 per HYFT's latest filing, from $4.4 million in the prior quarter.
- Across five years, Operating Expenses topped out at $5.1 billion in Q3 2023 and bottomed at $4978.1 in Q2 2026.
- Historically, Operating Expenses has averaged $995.1 million across 5 years, with a median of $6.5 million in 2022.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 138078.72% — and 2024, when it sank 99.91%.
- MindWalk Holdings' Operating Expenses stood at $8.0 million in 2022, then jumped by 53251.54% to $4.3 billion in 2023, then tumbled by 99.91% to $4.0 million in 2024, then fell by 1.3% to $3.9 million in 2025, then slumped by 99.87% to $4978.1 in 2026.
- Business Quant data shows HYFT's Operating Expenses at $4978.1 in Q2 2026, $4.4 million in Q1 2026, and $3.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 367.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 4,978.15 |
| Jan 31, 2026 | 4.42 Mn |
| Oct 31, 2025 | 3.92 Mn |
| Jul 31, 2025 | 4.14 Bn |
| Apr 30, 2025 | 15,474.79 |
| Jan 31, 2025 | 18.75 Mn |
| Oct 31, 2024 | 3.97 Mn |
| Jul 31, 2024 | 4.30 Bn |
| Apr 30, 2024 | 12.89 Mn |
| Jan 31, 2024 | 4.84 Mn |
| Oct 31, 2023 | 4.26 Bn |
| Jul 31, 2023 | 5.13 Bn |
| Apr 30, 2023 | 6.96 Mn |
| Jan 31, 2023 | 5.59 Mn |
| Oct 31, 2022 | 7.98 Mn |
| Jul 31, 2022 | 9.76 Mn |
| Apr 30, 2022 | 6.00 Mn |
| Jan 31, 2022 | 5.45 Mn |
| Oct 31, 2021 | 5,777.26 |
| Jul 31, 2021 | 4.86 Mn |